VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs PFE

PFE

In the past 12 months, PFE returned +2% while 0QQ6.L gained 1%.

0QQ6.L
0QQ6.L

Roche Holding AG

$423.14
-10.9%(1M)
Market Cap360.7B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio45.65
ROE41.2%
P/B Ratio9.11
Dividend Yield3.0%
PFE
PFE

Pfizer Inc.

$26.61
-2.8%(1M)
Market Cap151.3B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio19.86
ROE8.7%
P/B Ratio1.78
Dividend Yield6.3%
Performance Comparison

Historical returns across multiple timeframes

0QQ6.L

0QQ6.L

Roche Holding AG

+1.3%

1Y Return

PFE

PFE

Pfizer Inc.

+2.1%

1Y Return

0QQ6.L
0QQ6.L
PFE
PFE

Short Term

1M-6M

PFE
+4.3%

Medium Term

YTD-1Y

PFE
+3.9%

Long Term

3Y-10Y

0QQ6.L
+18.5%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 1PFE: 4
Metric0QQ6.LPFEWinner
P/E Ratio

Price to earnings ratio

45.6519.86PFE
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.572.47PFE
P/B Ratio

Price to book ratio

9.111.78PFE
P/FCF Ratio

Price to free cash flow ratio

20.5917.02PFE
EV/EBITDA

Enterprise value to EBITDA

12.7413.160QQ6.L
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 5PFE: 1
Metric0QQ6.LPFEWinner
Gross Margin

Gross profit margin

73.5%70.3%0QQ6.L
Operating Margin

Operating profit margin

28.4%24.7%0QQ6.L
Net Margin

Net profit margin

12.3%12.4%PFE
ROE

Return on equity

41.2%8.7%0QQ6.L
ROA

Return on assets

12.8%3.7%0QQ6.L
ROIC

Return on invested capital

18.8%8.8%0QQ6.L

Growth

Compare revenue and earnings growth rates

0QQ6.L: 5PFE: 1
Metric0QQ6.LPFEWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%-1.6%0QQ6.L
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%-14.6%0QQ6.L
Revenue Growth (5Y)

5-year revenue CAGR

1.1%8.5%PFE
EPS Growth (YoY)

Year-over-year EPS growth

55.9%-3.5%0QQ6.L
EPS Growth (3Y)

3-year EPS CAGR

1.1%-37.1%0QQ6.L
EPS Growth (5Y)

5-year EPS CAGR

-0.6%-3.5%0QQ6.L

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 4PFE: 1
Metric0QQ6.LPFEWinner
Debt/Equity

Debt to equity ratio

1.210.78PFE
Current Ratio

Current assets to current liabilities

1.291.160QQ6.L
Quick Ratio

Quick assets to current liabilities

1.020.870QQ6.L
Interest Coverage

EBIT to interest expense

10.735.780QQ6.L
Beta

Stock volatility vs market

0.210.410QQ6.L
Summary
0QQ6.L wins 3-1

Valuation

PFE

Profitability

0QQ6.L

Growth

0QQ6.L

Balance Sheet

0QQ6.L

PFE is more attractively valued. 0QQ6.L shows stronger profitability. 0QQ6.L demonstrates better growth. 0QQ6.L has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into 0QQ6.L and PFE with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/0QQ6.L/vs/PFE" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs PFE on stockvs.app
</a>